Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 673 of 6351
-
New hope for APOL1 kidney disease: targeted drug enters Mid-Stage trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and effect on Albuminuria of MZE829 in Adults with APOL1 Kidney Disease.
Phase 2 • Sponsor: Maze Therapeutics • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New hope for pancreatic cancer: novel drug combo enters final trial phase
Disease control Recruiting nowThis trial is a multi-center, randomized, open, parallel-group and positive-controlled phase III trial to evaluate the efficacy and safety of paclitaxel polymeric micelles for injection plus gemcitabine as first-line treatment of metastatic pancreatic cancer compared with nab-Pac…
Phase 3 • Sponsor: Shanghai Yizhong Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug targets genetic kidney disease in small trial
Disease control CompletedThe purpose of the study is to evaluate the efficacy, safety, and tolerability of Inaxaplin (IXP) in participants with proteinuric APOL1- mediated kidney disease (AMKD).
Phase 2 • Sponsor: Vertex Pharmaceuticals Incorporated • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
A conversation starter for kidney care: can a checklist give older patients a stronger voice?
Symptom relief Recruiting nowTo achieve the goal of reaching consensus about the preferred treatment option that best aligns with the goals and values of patients, the investigators developed a 'CKD Jumpstart- Tips" priming tool tailored for older adults with advanced CKD that is based on communication princ…
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
AI boosts kidney drug dosing: hope for membranous nephropathy patients
Disease control Recruiting nowMembranous nephropathy is an autoimmune disease affecting the kidney, and the most common cause of nephrotic syndrome in non-diabetic Caucasian adults. The course of this disease is highly variable from one individual to another, ranging from spontaneous remission to progressive …
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
ER syphilis screening for pregnant women could save lives
Diagnosis Recruiting nowThe purpose of this study is to offer routine lab-based and rapid point of care (POC) syphilis diagnostic testing in the emergency department (ED) and obstetrical (OB) triage , thereby increasing screening and treatment initiation for pregnant patients without prenatal care or wi…
Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 12:29 UTC
-
New combo aims to beat High-Risk leukemia and MDS
Disease control Recruiting nowThe study is a Phase II clinical trial. Patients will receive intensity-modulated total marrow irradiation (TMI) at a dose of 9 Gray (Gy) with standard myeloablative fludarabine intravenous (IV) and targeted busulfan (FluBu4) conditioning prior to allogeneic hematopoietic stem ce…
Phase 2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
AI may outsmart current system for liver transplant priority
Knowledge-focused Recruiting nowIntro: The present clinical research protocol is part of the LEOPARD European project (Grant n° 101080964 Horizon Europe) which aims to design and validate new predictive models of mortality among liver transplantation (LT) candidates. MELD based-liver graft allocation systems h…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC
-
A new strategy aims to keep older veterans safe from falls
Prevention Recruiting nowFalls are a common occurrence among older adults, and Veterans have an even higher risk of falling compared to non-Veterans. These falls often lead to severe health consequences, including traumatic brain injuries, hip fractures, emergency visits, hospitalizations, and even death…
Sponsor: VA Office of Research and Development • Aim: Prevention
Last updated Aug 16, 2026 00:00 UTC
-
New immune cell therapy aims to prevent leukemia return after transplant
Disease control OngoingThe goal of this clinical trial is to test BSB-1001 which is a new type of cellular therapy to treat blood cancers (AML, ALL and MDS). It will evaluate the safety of BSB-1001 and also determine whether it works to prevent relapse of your cancer.
Phase 1/2 • Sponsor: BlueSphere Bio, Inc • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Waterjet vs. scalpel: new trial tests gentler prostate cancer treatment
Disease control OngoingThis is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will…
Sponsor: PROCEPT BioRobotics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart attack survivors: could a dual ablation approach stop deadly rhythms?
Disease control Recruiting nowThe EPISODE VT trial is designed to compare efficacy and safety of two modalities for interventional treatment - endocardial ablation and endo-epicardial ablation in a population of patients with post myocardial infarction (ICD 10 - I25.2) ventricular tachycardias (ICD 10 - I47.2…
Sponsor: MEDICOVER SP Z O.O. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New shot could tame thyroid eye disease
Disease control OngoingThis is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED).
Phase 3 • Sponsor: Viridian Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New hope for young brain cancer patients: targeted drug combo enters phase 2 trial
Disease control Recruiting nowThe goal of this study is to determine the efficacy of the study drug olutasidenib to treat newly diagnosed pediatric and young adult patients with a high-grade glioma (HGG) harboring an IDH1 mutation. The main question the study aims to answer is whether the combination of olut…
Phase 2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
A new window into Babies' eyes: can advanced imaging improve care for premature infants?
Diagnosis Recruiting nowThe goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascula…
Sponsor: Vanderbilt University Medical Center • Aim: Diagnosis
Last updated Aug 06, 2026 00:00 UTC
-
New triple therapy could extend life for esophageal cancer patients
Disease control Recruiting nowThe goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.
Phase 3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Heart shield? diabetes drug tested to prevent chemo heart damage
Prevention Recruiting nowThe goal of this randomized, double-blind, placebo-controlled clinical trial is to determine whether dapagliflozin, a sodium-glucose cotransporter-2 (SGLT-2) inhibitor, can help prevent anthracycline-induced cardiotoxicity caused by anthracycline chemotherapy in adult women with …
Phase 2 • Sponsor: University Medical Centre Ljubljana • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
New hope for breast cancer spread to liver: targeted chemo trial opens
Disease control Recruiting nowStudy Objective: To Evaluate the Efficacy of Albumin-Bound Paclitaxel Combined with Nedaplatin via Hepatic Arterial Infusion as Later-Line Therapy for Breast Cancer Patients with Liver Metastases After Failure of Standard Treatment. Outcome Measures:Primary Outcome: Liver Progre…
Phase 2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New HIV strategy aims to curb epidemic among nigerian teens
Disease control Recruiting nowTwo combination interventions (HIV Case Finding Intervention and HIV Treatment Intervention), each with mHealth and Peer Navigation components, will be evaluated in two 48-week parallel hybrid effectiveness/implementation trials among youth aged 15-24 in Nigeria.
Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could a higher dose of letrozole unlock fertility for women with PCOS?
Disease control CompletedThe goal of this clinical trial is to learn if drug letrozole 10mg for 5 days works better than letrozole 5mg for 5 days for ovarian stimulation in infertile women with PCOS. It will also learn about the safety of drug letrozole . The main questions it aims to answer are: What m…
Sponsor: Mst.Sumyara Khatun • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC